万泰生物 - Financials

万泰生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
+Revenue	2.2B	5.5B	11.2B	5.8B	2.4B	1.2B	983.0M	950.0M	844.0M	681.0M	596.0M	499.0M
Revenue Growth %	-59.3%	-50.7%	94.5%	144.3%	98.8%	20.4%	3.5%	12.6%	23.9%	14.3%	19.4%	--
Total Revenue	2.2B	5.5B	11.2B	5.8B	2.4B	1.2B	983.0M	950.0M	844.0M	681.0M	596.0M	499.0M
Cost Of Revenue	759.0M	873.0M	1.2B	818.0M	442.0M	331.0M	269.0M	281.0M	230.0M	175.0M	142.0M	117.0M
+Gross Profit	1.5B	4.6B	10.0B	4.9B	1.9B	853.0M	714.0M	669.0M	614.0M	506.0M	454.0M	382.0M
Gross Margin %	66.2%	84.2%	89.5%	85.8%	81.2%	72.0%	72.6%	70.4%	72.7%	74.3%	76.2%	76.6%
Total Operating Cost	2.5B	4.3B	5.9B	3.5B	1.6B	1.0B	853.0M	822.0M	713.0M	556.0M	473.0M	397.0M
Selling Expenses	438.0M	1.5B	3.3B	1.7B	691.0M	333.0M	266.0M	266.0M	252.0M	191.0M	171.0M	151.0M
Admin Expenses	347.0M	353.0M	235.0M	182.0M	116.0M	172.0M	154.0M	93.9M	96.7M	77.4M	153.0M	118.0M
Rd Expenses	886.0M	1.2B	1.1B	682.0M	314.0M	166.0M	138.0M	159.0M	130.0M	109.0M	--	--
Finance Expenses	-58.1M	-93.0M	-61.6M	5.2M	11.4M	-7.6M	-757,500	2.6M	-5.4M	-6.0M	-752,300	-778,600
+Operating Income	93.8M	1.4B	5.6B	2.3B	775.0M	218.0M	289.0M	179.0M	131.0M	122.0M	115.0M	96.2M
Operating Margin %	4.2%	25.4%	50.0%	40.5%	32.9%	18.4%	29.4%	18.8%	15.5%	17.9%	19.3%	19.3%
Non Operating Income	2.6M	2.3M	1.2M	658,600	312,100	55,600	1.3M	310,100	22.1M	11.9M	19.3M	7.3M
Non Operating Expenses	29.0M	10.4M	14.5M	5.0M	11.1M	1.6M	121,100	502,800	870,000	2.7M	296,400	350,300
Investment Income	110.0M	98.9M	36.1M	11.2M	13.6M	13.7M	2.1M	4.5M	263,700	-3.1M	-7.7M	-5.5M
Fair Value Change Income	36.7M	24.7M	10.0M	28,000	348,600	196,500	4,600	44,000	18,400	1,500	-6,400	17,000
Asset Disposal Income	7.9M	221,600	59,800	-721,600	525,200	-1.4M	134.0M	98,000	-117,100	-12,300	--	--
Asset Impairment Loss	104.0M	460.0M	20.5M	29.8M	29.2M	18.5M	19.1M	13.6M	4.5M	5.8M	5.0M	8.7M
Other Income	211.0M	82.8M	224.0M	85.0M	47.8M	49.2M	24.3M	46.9M	--	--	--	--
Income Before Tax	67.5M	1.4B	5.6B	2.3B	764.0M	217.0M	290.0M	179.0M	153.0M	131.0M	134.0M	103.0M
Income Tax	-41.6M	147.0M	719.0M	245.0M	82.6M	6.5M	-2.6M	28.2M	21.2M	24.6M	15.8M	23.3M
+Net Income	109.0M	1.2B	4.9B	2.1B	682.0M	210.0M	293.0M	150.0M	131.0M	106.0M	118.0M	79.9M
Net Margin %	4.9%	22.6%	43.5%	36.2%	29.0%	17.7%	29.8%	15.8%	15.5%	15.6%	19.8%	16.0%
Net Income Attributable	106.0M	1.2B	4.7B	2.0B	677.0M	209.0M	293.0M	150.0M	148.0M	119.0M	118.0M	79.8M
Minority Interest	2.9M	-1.2M	128.0M	57.7M	4.8M	1.4M	-191,700	-48,000	-16.7M	-12.9M	--	34,100
Eps Basic	0.08	0.99	3.79	2.30	1.15	0.54	0.78	0.42	0.41	0.33	0.33	0.23
Eps Diluted	0.08	0.99	3.79	2.30	1.15	0.54	0.78	0.42	0.41	0.33	0.33	0.23

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash And Equivalents	2.4B	3.8B	5.2B	1.4B	711.0M	284.0M	427.0M	340.0M	308.0M	321.0M	273.0M	133.0M
Trading Financial Assets	2.5B	2.1B	2.0B	40.4M	50.4M	58.0M	343,700	671,400	619,700	301,300	64,500	121,700
Accounts Receivable	2.0B	3.0B	3.9B	2.3B	691.0M	251.0M	185.0M	191.0M	--	--	114.0M	111.0M
Notes Receivable	4.2M	4.6M	8.1M	12.1M	7.3M	9.9M	7.9M	4.2M	--	--	7.8M	3.6M
Notes And Accounts Receivable	2.0B	3.0B	3.9B	2.3B	699.0M	261.0M	193.0M	195.0M	171.0M	135.0M	122.0M	114.0M
Prepayments	13.2M	12.3M	32.8M	68.8M	26.2M	16.8M	9.1M	4.6M	8.0M	7.1M	6.1M	7.0M
Inventory	863.0M	905.0M	869.0M	593.0M	400.0M	236.0M	219.0M	179.0M	152.0M	106.0M	85.5M	76.9M
Total Current Assets	8.4B	10.3B	12.2B	4.6B	2.0B	886.0M	871.0M	760.0M	655.0M	585.0M	501.0M	363.0M
Long Term Equity Investment	714,200	714,200	--	--	--	23.4M	17.9M	15.8M	5.3M	5.0M	18.1M	17.5M
Fixed Assets	--	1.8B	1.5B	728.0M	559.0M	546.0M	561.0M	509.0M	--	205.0M	116.0M	118.0M
Fixed Assets Total	1.9B	1.8B	1.5B	728.0M	559.0M	546.0M	561.0M	509.0M	217.0M	205.0M	116.0M	118.0M
Construction In Progress	--	815.0M	721.0M	924.0M	231.0M	81.7M	23.5M	61.7M	--	65.0M	94.8M	40.7M
Construction In Progress Total	1.5B	815.0M	721.0M	924.0M	231.0M	81.7M	23.5M	61.7M	137.0M	65.0M	94.8M	40.7M
Intangible Assets	512.0M	508.0M	292.0M	295.0M	234.0M	242.0M	249.0M	254.0M	263.0M	193.0M	55.1M	56.3M
Long Term Deferred Expenses	163.0M	79.8M	132.0M	22.0M	20.5M	17.7M	16.1M	16.3M	17.7M	19.2M	--	--
Total Non Current Assets	6.3B	5.4B	4.0B	2.4B	1.5B	1.3B	944.0M	896.0M	800.0M	517.0M	305.0M	244.0M
Total Assets	14.7B	15.7B	16.2B	7.0B	3.5B	2.2B	1.8B	1.7B	1.5B	1.1B	806.0M	607.0M
Short Term Borrowings	104.0M	81.1M	140.0M	236.0M	77.7M	--	--	100.0M	--	--	31.0M	30.0M
Accounts Payable	420.0M	300.0M	317.0M	193.0M	113.0M	85.0M	74.4M	86.6M	--	--	28.0M	32.1M
Advance Receipts	--	--	--	--	--	123.0M	38.7M	23.5M	27.8M	15.3M	11.4M	9.1M
Contract Liabilities	48.1M	70.4M	82.3M	70.3M	40.9M	--	--	--	--	--	--	--
Total Current Liabilities	2.0B	2.7B	3.5B	2.4B	829.0M	492.0M	344.0M	571.0M	421.0M	303.0M	169.0M	177.0M
Long Term Borrowings	94.2M	115.0M	102.0M	4.9M	--	21.0M	21.0M	118.0M	--	--	--	--
Total Non Current Liabilities	229.0M	161.0M	179.0M	118.0M	94.3M	92.2M	99.9M	186.0M	73.6M	75.4M	56.6M	47.8M
Total Liabilities	2.2B	2.8B	3.7B	2.5B	923.0M	584.0M	444.0M	757.0M	495.0M	379.0M	225.0M	225.0M
Paid In Capital	1.3B	1.3B	906.0M	607.0M	434.0M	390.0M	390.0M	361.0M	361.0M	361.0M	86.0M	82.5M
Capital Reserve	3.1B	3.3B	3.7B	446.0M	446.0M	172.0M	172.0M	22.3M	183.0M	108.0M	108.0M	32.0M
Surplus Reserve	719.0M	675.0M	549.0M	262.0M	228.0M	197.0M	175.0M	145.0M	102.0M	75.7M	59.7M	47.2M
Retained Earnings	7.2B	7.6B	7.4B	3.2B	1.4B	799.0M	613.0M	349.0M	243.0M	145.0M	326.0M	220.0M
Minority Equity	185.0M	183.0M	224.0M	96.2M	26.7M	21.9M	20.5M	20.7M	70.6M	32.7M	--	--
Equity Attributable	12.3B	12.7B	12.3B	4.5B	2.6B	1.6B	1.4B	878.0M	889.0M	690.0M	580.0M	382.0M
Total Equity	12.4B	12.9B	12.6B	4.6B	2.6B	1.6B	1.4B	899.0M	960.0M	723.0M	580.0M	382.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash From Sales	3.3B	6.7B	9.8B	4.3B	1.9B	1.2B	1.0B	964.0M	861.0M	703.0M	625.0M	489.0M
Tax Refunds Received	21.9M	145.0M	35.5M	--	--	--	--	--	--	--	--	--
Total Operating Cash Inflow	3.7B	7.1B	10.1B	4.4B	2.0B	1.3B	1.1B	1.0B	896.0M	743.0M	672.0M	537.0M
Cash Paid For Goods	623.0M	745.0M	1.0B	940.0M	485.0M	305.0M	268.0M	285.0M	271.0M	207.0M	166.0M	142.0M
Cash Paid To Employees	1.0B	1.1B	858.0M	554.0M	346.0M	268.0M	220.0M	170.0M	133.0M	115.0M	86.8M	72.6M
Taxes Paid	136.0M	682.0M	1.2B	296.0M	145.0M	99.9M	86.1M	76.7M	82.4M	57.6M	58.7M	55.6M
Total Operating Cash Outflow	3.3B	5.5B	6.0B	2.8B	1.5B	1.0B	909.0M	870.0M	766.0M	591.0M	540.0M	439.0M
Operating Cash Flow	355.0M	1.5B	4.1B	1.7B	468.0M	273.0M	208.0M	147.0M	129.0M	152.0M	132.0M	97.8M
Total Investing Cash Inflow	6.1B	2.2B	1.1B	134.0M	661.0M	1.1B	657.0M	281.0M	156.0M	9.9M	14.2M	12.6M
Total Investing Cash Outflow	7.6B	4.2B	4.7B	1.1B	957.0M	1.2B	1.0B	582.0M	354.0M	235.0M	85.7M	119.0M
Investing Cash Flow	-1.5B	-2.1B	-3.5B	-1.0B	-295.0M	-198.0M	-353.0M	-302.0M	-198.0M	-225.0M	-71.5M	-106.0M
Cash From Borrowings	231.0M	186.0M	352.0M	240.0M	90.4M	--	--	218.0M	--	--	1.0M	30.0M
Dividends And Interest Paid	411.0M	947.0M	128.0M	113.0M	1.7M	1.0M	6.3M	4.6M	--	105.0M	2.1M	17.3M
Debt Repayments	252.0M	148.0M	346.0M	77.6M	33.8M	--	197.0M	--	--	31.0M	--	--
Total Financing Cash Inflow	309.0M	240.0M	3.8B	259.0M	440.0M	4.5M	200.0M	220.0M	106.0M	106.0M	80.8M	30.0M
Total Financing Cash Outflow	922.0M	1.1B	688.0M	206.0M	60.0M	9.7M	229.0M	10.2M	--	136.0M	2.4M	17.6M
Financing Cash Flow	-613.0M	-893.0M	3.1B	52.8M	380.0M	-5.2M	-29.1M	209.0M	106.0M	-30.9M	78.4M	12.4M
Net Change In Cash	-1.8B	-1.4B	3.8B	712.0M	544.0M	69.4M	-172.0M	54.6M	37.8M	-104.0M	139.0M	3.9M
Ending Cash Balance	2.0B	3.8B	5.2B	1.4B	701.0M	158.0M	88.5M	261.0M	206.0M	168.0M	273.0M	133.0M
Capex	887.0M	1.2B	930.0M	1.0B	390.0M	162.0M	246.0M	215.0M	131.0M	77.9M	77.4M	82.1M